Palliative Home Care and Hospice Ward, ASIH Stockholm Södra, Älvsjö, Sweden.
Department of Oncology, Södersjukhuset, Stockholm, Sweden.
Infect Dis (Lond). 2021 Sep;53(9):719-723. doi: 10.1080/23744235.2021.1922752. Epub 2021 May 8.
Catheter related blood stream infections is a complication in patients with central venous catheter. The aim of this study was to compare vancomycin-heparin-lock and non-heparin, high-dose vancomycin-lock as treatment in patients admitted to palliative home care. With non-heparin, high-dose vancomycin-lock a high concentration of 5 mg/mL vancomycin is attained instead of only 500 ug/mL when dissolved in heparin. The non-heparin method also has the advantage of being easier and cheaper but might entail an increased risk of clotting.
Medical records from patients enrolled at a palliative home care unit in Stockholm between 2016 and 2018 were reviewed retrospectively. Three divisions used vancomycin-heparin-lock and the other 3 divisions used non-heparin, high-dose vancomycin-lock. Inclusion criteria were a central venous catheter related blood stream infection treated with one of the two methods for >7 days and a follow-up blood culture at the end of treatment.
Twenty-five patients fulfilled the inclusion criteria, 12 treated with vancomycin-heparin-lock and 13 with non-heparin, high-dose vancomycin-lock. There was no significant difference in resolved infections between the two treatments, 6 of 12 for vancomycin-heparin-lock and 10 of 13 for non-heparin, high-dose vancomycin-lock ( = .23). In the non-heparin group one central venous catheter was removed due to clotting although the infection had resolved. Overall, removal of central venous catheter was similar in the two groups (6 of 12 and 4 of 13, = .43).
The current study does not support superiority of one treatment over the other. However, larger, randomized studies are needed, before firm conclusions can be drawn.
导管相关血流感染是中心静脉导管患者的一种并发症。本研究旨在比较万古霉素-肝素锁和非肝素、高剂量万古霉素锁在姑息性家庭护理患者中的治疗效果。与肝素相比,非肝素、高剂量万古霉素锁可达到 5mg/mL 的高万古霉素浓度,而肝素中仅为 500μg/mL。非肝素法还有操作简单、成本低的优点,但可能会增加血栓形成的风险。
回顾性分析 2016 年至 2018 年斯德哥尔摩姑息性家庭护理病房收治的患者的病历。3 个科室使用万古霉素-肝素锁,其他 3 个科室使用非肝素、高剂量万古霉素锁。纳入标准为采用两种方法之一治疗>7 天的中心静脉导管相关血流感染,治疗结束时进行后续血培养。
25 例患者符合纳入标准,12 例采用万古霉素-肝素锁治疗,13 例采用非肝素、高剂量万古霉素锁治疗。两种治疗方法的感染治愈率无显著差异,万古霉素-肝素锁组 6 例,非肝素、高剂量万古霉素锁组 10 例( = .23)。在非肝素组,尽管感染已得到解决,但由于血栓形成,有 1 根中心静脉导管被移除。总的来说,两组中心静脉导管的移除情况相似(6/12 和 4/13, = .43)。
本研究结果不支持一种治疗方法优于另一种。然而,在得出明确结论之前,需要进行更大规模的随机研究。